![Ivor MacLeod](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 315 698 $ al 31/08/2026
Ivor MacLeod is currently Chief Financial Officer at SCYNEXIS, Inc. since 2022.
Formerly, Mr. MacLeod was Chief Financial & Accounting Officer at Athersys, Inc. from 2021 to 2022, Chief Financial & Compliance Officer, SVP at Eisai, Inc. from 2015 to 2018, Vice President-Finance at Merck & Co., Inc. from 2012 to 2015, and Vice President-Finance & Information Technology at Hoffmann-La Roche, Inc. Education includes an undergraduate degree from the University of St. Andrews and an MBA from Eller College of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SCYNEXIS, INC. 0,61 % | 01/04/2026 | 60.363 ( 0,61 % ) | 315 698 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SCYNEXIS, INC. | Director Financiero/CFO | 24/10/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| ATHERSYS, INC. | Director Financiero/CFO | 30/06/2022 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Director Financiero/CFO | 01/01/2018 |
| MERCK & CO., INC. | Director Financiero/CFO | 01/01/2015 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
University of St. Andrews
 University of St. Andrews Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Athersys, Inc.
 Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
Eller College of Management
 Eller College of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
